Semi-Annual Statement Of Cash Flows

Human Metabolome Technologies, Inc. - Filing #7544232

Concept As at
2023-06-30
2022-07-01 to
2023-06-30
2021-07-01 to
2022-06-30
As at
2022-06-30
As at
2021-06-30
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
306,176,000 JPY
324,636,000 JPY
Interest and dividends received
14,000 JPY
11,000 JPY
Interest paid
-2,265,000 JPY
-2,214,000 JPY
Net cash provided by (used in) operating activities
284,962,000 JPY
324,033,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-98,786,000 JPY
-141,973,000 JPY
Purchase of investment securities
JPY
-7,000,000 JPY
Net cash provided by (used in) investing activities
-116,755,000 JPY
-152,314,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-23,000 JPY
JPY
Net cash provided by (used in) financing activities
-13,754,000 JPY
80,491,000 JPY
Effect of exchange rate change on cash and cash equivalents
-2,407,000 JPY
7,483,000 JPY
Net increase (decrease) in cash and cash equivalents
152,045,000 JPY
259,693,000 JPY
Cash and cash equivalents
1,656,789,000 JPY
1,504,744,000 JPY
1,245,050,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.